Treatment of patients with coexisting spondyloarthritis (SpA) and inflammatory bowel disease (IBD) often requires multidisciplinary collaboration between gastroenterologists and rheumatologists.
To describe the results of the first Delphi consensus to define shared therapeutic strategies for the best management of patients with coexisting SpA and IBD.
A scientific steering committee of 10 Italian experts in the field of SpA and IBD developed 27 statements on 5 possible clinical scenarios and selected 40 specialists from across Italy, both gastroenterologists and rheumatologists, to vote them using a Delphi method. Each participant expressed a level of agreement on each statement using a 5-point scale (1 = “absolutely disagree”; 5 = “absolutely agree”). Total cumulative agreement was defined as the sum of the percentage of responses to items 4 (“agree”) and 5 (“absolutely agree”). Total cumulative agreement ≥70% defined consensus for each statement.
After the first round, positive consensus was reached for 22 statements. Statements without consensus were discussed in a plenary session before the second vote. Positive consensus was then reached in all statements, with final total cumulative agreement ranging from 80% to 100%.
This is the first Delphi consensus defining specific treatment algorithms for patients with coexisting SpA and IBD.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Digestive and Liver Disease
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history.Gut. 1998; 42: 387-391
- Musculoskeletal manifestations in a population-based cohort of inflammatory bowel disease patients.Scand J Gastroenterol. 2001; 36: 1307-1313
- The prevalence of extraintestinal manifestations and HLA association in patients with inflammatory bowel disease.Rheumatol Int. 2006; 26: 663-668
- Prevalence of self-reported spondyloarthritis features in a cohort of patients with inflammatory bowel disease.Can J Gastroenterol. 2013; 27: 199-205
- Classifying back pain and peripheral joint complaints in inflammatory bowel disease patients: a prospective longitudinal follow-up study.J Crohns Colitis. 2016; 10: 166-175
- The Italian Society of Gastroenterology (SIGE) and the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) Clinical Practice Guidelines: the use of tumor necrosis factor-alpha antagonist therapy in inflammatory bowel disease.Dig Liver Dis. 2011; 43: 1-20
- The second European evidence-based consensus on the diagnosis and management of Crohn’s disease: current management.J Crohns Colitis. 2010; 4: 28-62
- Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management.J Crohns Colitis. 2012; 6: 991-1030
- 2010 update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis.Ann Rheum Dis. 2011; 70: 905-908
- European league against rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies.Ann Rheum Dis. 2012; 71: 4-12
- Italian expert panel on the management of patients with coexisting spondyloarthritis and inflammatory bowel disease.Autoimmun Rev. 2014; 13: 822-830
- The second European evidence-based consensus on the diagnosis and management of Crohn’s disease: definitions and diagnosis.J Crohn’s Colitis. 2010; 4: 7-27
- Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 1: definitions and diagnosis.J Crohn’s Colitis. 2012; 6: 965-990
- Optimizing anti-TNF treatments in inflammatory bowel disease.Autoimmun Rev. 2014; 13: 24-30
- The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis.Ann Rheum Dis. 2009; 68: ii1-44
- Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force.Ann Rheum Dis. 2014; 73: 6-16
- Recommendations for musculoskeletal ultrasonography by rheumatologists: setting global standards for best practice by expert consensus.Arthritis Rheum. 2005; 53: 83-92
- Consensus-based standards for best supportive care in clinical trials in advanced cancer.Lancet Oncol. 2012; 13: e77-82
- American College of Chest Physicians consensus statement on the management of dyspnea in patients with advanced lung or heart disease.Chest. 2010; 137: 674-691
- Infliximab for induction and maintenance therapy for ulcerative colitis.N Engl J Med. 2005; 353: 2462-2476
- Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn’s disease: the CLASSIC-I trial.Gastroenterology. 2006; 130: 323-333
- Adalimumab for maintenance treatment of Crohn’s disease: results of the CLASSIC II trial.Gut. 2007; 56: 1232-1239
- Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitis.Gastroenterology. 2012; 142: 257-265.e3
- Subcutaneous golimumab induces clinical response and remission in patients with moderate-to-severe ulcerative colitis.Gastroenterology. 2014; 146: 85-95
- Subcutaneous golimumab maintains clinical response in patients with moderate-to-severe ulcerative colitis.Gastroenterology. 2014; 146: 96-109
Remicade Summary of Product Characteristics [online]. Accessed June 07, 2017. Available at http://www.ema.europa.eu/docs/en_GB/document_library/EPAR__Product_Information/human/000240/WC500050888.pdf.
- Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.Cochrane Database Syst Rev. 2012; 10: CD000544
- Safety of celecoxib in patients with ulcerative colitis in remission: a randomised placebo controlled pilot study.Clin Gastroenterol Hepatol. 2006; 4: 203-211
- The gastrointestinal safety and effect on disease activity of etoricoxib, a selective COX-2 inhibitor in inflammatory bowel diseases.Am J Gastroenterol. 2006; 101: 311-317
- 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis.Ann Rheum Dis. 2011; 70: 896-904
- Tumour necrosis factor alpha inhibitor therapy and rehabilitation for the treatment of ankylosing spondylitis: a systematic review.Semin Arthritis Rheum. 2015; 44: 542-550
- Effectiveness of rehabilitation in active ankylosing spondylitis assessed by the ASAS response criteria.Rheumatology (Oxford). 2007; 46: 1672-1675
- Effects of a combination treatment of an intensive rehabilitation program and etanercept in patients with ankylosing spondylitis: a pilot study.J Rheumatol. 2006; 33: 2029-2034
- Can we reduce the dosage of biologics in spondyloarthritis?.Autoimmun Rev. 2013; 12: 691-693
- Methotrexate in peripheral spondyloarthritis including psoriatic arthritis: a need for further evaluation.Rheumatology (Oxford). 2012; 51: 1343-1344
- An experimental application of the Delphi method to the use of experts. Publication RM-727-PR.Rand Corporation, Santa Monica, CA1962
- Research guidelines for the Delphi survey technique.J Adv Nurs. 2000; 32: 1008-1015
- Nursing administration research priorities: a national Delphi study.J Nurs Adm. 1998; 28: 7-11
- Delphi technique: characteristics and sequence model to the use of experts.Manage Sci. 1963; 9: 458-467
- The Delphi technique: a worthwhile research approach for nursing?.J Adv Nurs. 1994; 19: 1221-1225
- Consensus development methods, and their use in clinical guideline development.Health Technol Assess. 1998; 2 (1–88): I-IV
- The Delphi technique: myths and realities.J Adv Nurs. 2003; 41: 376-382
- The use of consensus methods and expert panels in pharmacoeconomic studies. Practical applications and methodological shortcomings.Pharmacoeconomics. 1997; 12: 121-129
- Consensus methods for medical and health services research.Br Med J. 1995; 311: 376-380
Published online: June 22, 2017
Accepted: June 12, 2017
Received: March 24, 2017
© 2017 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.